$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Holding on to my tickets from last month. The party has only started IMO.
DEWM
The Cannabis sector is waking up again.
Looks like a "wait and see" scenario. Lots of confidence out there as this takes a day to breath.
Investors are showing their confidence in SNVP with the way it's trading.
Steady as she goes :)
The temperature is rising. Still lots of room to run. This gem has a low SS and float :)
SNVP
Got my tickets this morning. I haven't posted on iHub for a long time but this one has me very interested. Get the news out over the weekend and we'll have a monster to contend with next week.
GLTA!!!
Trading halted in Canada for over two years now. Investor relations told me that it's something they're aware of. That was two years ago. they don't respond to my emails when I follow up with them.
Can this ticker be traded with the TD Ameritrade brokerage?
Thanks in advance.
Trading has been halted in Canada for a few years now. Regulatory compliance is a serious issue with this company. I've contacted investor relations many times about this issue and all they do is blow smoke up my @rse !!!
No response from IR regarding the trading halt in Canada.
Making some noise and hoping that CBIS will resolve this!
There would be a lot more shares traded if this security wasn't halted in Canada. It's been over a year now. I'm up over 100% and can't trade my shares.
Get your act together CBIS !!!!!!
The ticker has been halted in Canada.
Trading halt in Canada.
Trading of CBIS is halted in Canada over a compliance issue. I wish that CBIS would fix that. It's been approx a year now.
Last year the 10-k was released on March 31.
This year . . . how is anyone supposed to know?
Picked up some shares today. The LCBO is perfect. I'll be able to pick up my buds, beer, booze and wine all at one location. A "one-stop" party shop. I can't think of a better organization to distribute pot in Ontario.
The stock has been halted in Canada because they haven't filed.
They seriously need to get their act together. Trading has been halted in Canada because they failed to be compliant.
I have to watch thousands in profits disappear because they can't get their act together. What a bunch of punks!!!!!
multi day runner
PWDY
No dilution . . . .
PWDY
chomp, chomp, chomp
pwdy
yep. Been here before. We churn for a bit before the next leg
2nd leg by EOD
PWDY
by EOD, IMO
We'll see
Blast off !!!!!
PWDY
CBIS * NEWS *
COLORADO SPRINGS, CO--(Marketwired - Jul 16, 2015) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine and related consulting, is pleased to announce guidance in regards to its State-by-State initiatives, including its new product releases.
On the forefront are the California new product releases. The Company has signed a research and distribution agreement with Cannabis Science Research Foundation (CSRF). The CSRF will be responsible for the release and distribution of the CBIS products for its initial State-by-State initiatives in California. The CSRF distribution agreement is due to the committed focus CBIS has on its federal drug development program. As a result of this new agreement with CSRF the Cannabis Science Patient Access Center will be moved to the CSRF website as well.
Please visit:
http://cannabisscienceresearchfoundation.org
http://cannabisscienceresearchfoundation.org/research/product-research
http://pac.cannabisscienceresearchfoundation.org
CSRF will be responsible for all of the CBIS State-by-State initiatives followed by Colorado, Washington, and subsequent States as scheduled products become available for distribution. The much-anticipated California release includes new extract products that will be the first in line and scheduled for release next week in California. This first batch of extracts will be followed by the second batch consisting of pill type capsules for oral consumption. These initial products will be available in a variety of dosage strengths, and subsequent products will be released in succession throughout the State of California.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Contact:
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond@cannabisscience.com
Tel: 1.888.889.0888
Direct: 1.310.650.3788
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1.888.889.0888
Cannabis Science, Inc.
Mr. Derwin A. Wallace
Finance & Investor Relations
info@cannabisscience.com
Tel: 1.888.889.0888
Direct: 1.404.500.4950
In PWDY
They better give investors a reason to buy or else their little ATM is going to be broken for good.
BLTA
Oregon marijuana legalization going into effect on July 1.
CBIS
BLTA a bullish double bottom chart pattern could be in the making if support holds and we bounce. That's a big IF lol
BLTA this dip is awesome!!!!
BLTA some buying on a Friday hmmmm . . . . . . .
BLTA easy to kick when it's down.
BLTA loading zone . . . .
BLTA weekly chart looks oversold.
BLTA bottom fishing season could end anytime . . . . .
BLTA some peeps won't have tickets.
HEMP pot sector looks oversold. Churning . . . .
CBIS churning . . . . .